Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc announced on March 3, 2026, that it purchased 192,000 ordinary shares on March 2, 2026, as part of its $250 million share repurchase program. The average price paid per share was 1,257.79 pence, with the lowest at 1,236.00 pence and the highest at 1,288.00 pence. This brings the total shares repurchased since February 26, 2026, to 472,000, costing £6.2 million. Following these transactions, Hikma holds 12,833,233 shares in treasury, with 221,414,453 ordinary shares currently in issue.

Disclaimer*

UK 100

Latest directors dealings